本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Forte BioSciences Inc

13.66
-0.1800-1.30%
盘后13.660.00000.00%16:40 EDT
成交量:2.37万
成交额:32.96万
市值:1.67亿
市盈率:-1.66
高:14.49
开:13.84
低:13.35
收:13.84
数据加载中...
2023/07/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/27

重要事件披露

Form 8-K - Current report
2023/05/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/31

重要事件披露

8-K - Current report
2023/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/09

重要事件披露

8-K - Current report
2023/01/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership